• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nautilus Biotechnology Inc (NQ: NAUT )

    2.640 +0.070 (+2.72%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Nautilus Biotechnology Inc

    < Previous 1 2 3 4 Next >
    Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award
    Dr. Mallick to be inducted into the Academy for Radiology and Biomedical Imaging Research’s esteemed Council of Distinguished Investigators for his outstanding contributions to medical imaging 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Reports Third Quarter 2024 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer
    Industry veteran brings multidisciplinary expertise leading Mass Spectrometry division at Agilent Technologies to a company building a platform to power next-generation proteomics 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q2 2024
    NAUT stock results show that Nautilus Biotechnology beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Nautilus Biotechnology Reports Second Quarter 2024 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    NAUT Stock Earnings: Nautilus Biotechnology Beats EPS for Q1 2024
    NAUT stock results show that Nautilus Biotechnology beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Nautilus Biotechnology Reports First Quarter 2024 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award
    Society award recognizes Dr. Mallick’s decades of innovative leadership and science advancing the field of computational proteomics 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development
    Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively quantifying the proteome 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Reports Third Quarter 2023 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Williams-Sonoma, ESS Tech And Other Big Stocks Moving Higher On Monday
    U.S. stocks traded lower, with the Dow Jones falling around 100 points on Monday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Farfetch, Faraday Future Intelligent Electric, VinFast, And Other Stocks Moving Lower On Friday
    U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Friday. Here are some big stocks recording gains in today’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    US Stocks Sink; Deere Shares Fall Despite Earnings Beat
    U.S. stocks traded down this morning with the Nasdaq Composite falling more than 101 points on Friday. The Dow traded down 0.23% to 34,396.96 while the NASDAQ fell 0.91% to 13,196.22. The S&P 500 also... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Nautilus Biotechnology to Participate in Upcoming August Investor Conferences
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology Reports Second Quarter 2023 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.